News Stocks Rekvina Laboratories Appoints Jay Chintan Patel as Independent Director for 5-Year TermRekvina Laboratories Appoints Jay Chintan Patel as Independent Director for 5-Year Term
Rekvina Laboratories Limited appointed Jay Chintan Patel as Additional Non-Executive Independent Director on January 29, 2026, for a 5-year term ending January 28, 2031. Patel, Founder and Director of Duchas Technologies Private Limited, brings expertise in artificial intelligence, biometrics, and digital products. The appointment complies with all SEBI regulations and requires shareholder approval.
*this image is generated using AI for illustrative purposes only.
Rekvina Laboratories Limited has appointed Jay Chintan Patel as Additional Non-Executive Independent Director during its board meeting held on January 29, 2026. The appointment was approved pursuant to the provisions of the Companies Act, 2013 and SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
Appointment Details
The company provided comprehensive details regarding the new directorship appointment:
| Parameter: | Details |
|---|---|
| Director Name: | Jay Chintan Patel |
| DIN: | 10147916 |
| Position: | Additional Non-Executive Independent Director |
| Appointment Date: | January 29, 2026 |
| Term Duration: | 5 consecutive years |
| Term End Date: | January 28, 2031 |
| Status: | Subject to requisite approval of members |
Professional Background
Jay Patel brings significant entrepreneurial and technology expertise to the board. He serves as Founder and Director of Duchas Technologies Private Limited, a DPIIT and Startup India-recognized startup. His professional focus encompasses building and scaling innovative solutions across multiple technology domains.
Patel's areas of specialization include:
- Artificial intelligence systems
- Biometric technologies
- Digital product development
- Advanced biometric systems
- Next-generation AI communication tools
Leadership Experience
The newly appointed director demonstrates extensive leadership capabilities in technology-driven environments. His experience spans strategic decision-making, product development, and organizational growth management. Patel has successfully managed cross-functional teams while guiding interns and collaborators throughout various project phases.
His leadership approach focuses on building sustainable technology-driven products with long-term global potential. The director has experience presenting to investors and stakeholders, ensuring innovation translates into practical, market-ready solutions.
Regulatory Compliance
Rekvina Laboratories confirmed full compliance with regulatory requirements for the appointment. In accordance with SEBI Letter dated June 14, 2018 and BSE Circular List/COMP/14/2018-19 dated June 20, 2018, the company verified that Jay Chintan Patel has not been debarred from holding directorship by SEBI or any other authority.
The company also disclosed that the new director maintains no relationships with existing board members, ensuring independence in his directorial capacity. The appointment follows all disclosure requirements under Regulation 30 of SEBI (LODR) Regulations, 2015 and SEBI Circular No. SEBI/HO/CFD/CFDPoD-1/CIR/2023/123 dated July 13, 2023.
15
